View more in
Cancer

ALLO-501A With ALLO-647 Lymphodepletion Shows Early Efficacy in Relapsed/Refractory Large B-Cell Lymphoma

onclive.com
 2021-06-11

Treatment with the allogeneic CAR T-cell product ALLO-501A elicited encouraging signals of clinical activity when used with ALLO-647 lymphodepletion in patients with relapsed/refractory large B-cell lymphoma who did not previously receive autologous CAR T-cell therapy. Treatment with the allogeneic CAR T-cell product ALLO-501A elicited encouraging signals of clinical activity when...

www.onclive.com

Comments / 0

Comments / 0